Boston Megan has filed 6 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 200000 shares of Benitec Biopharma Inc. ($BNTC) on November 18, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 18, 2025 | Benitec Biopharma Inc. | $BNTC | Boston Megan | Chief Financial Officer | A | Options (right to buy) | 200000 | $0.00 | 200,000.0000 | 37,254,839 | 9999.99% | 0.54% |
| Dec. 9, 2024 | Benitec Biopharma Inc. | $BNTC | Boston Megan | Executive Director | A | Options (right to buy) | 720000 | $0.00 | 720,000.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2024 | Benitec Biopharma Inc. | $BNTC | Boston Megan | Executive Director | A | Options (right to buy) | 200004 | $0.00 | 200,004.0000 | 0 | 9999.99% | 0.00% |
| Aug. 11, 2023 | Benitec Biopharma Inc. | $BNTC | Boston Megan | Executive Director | P | Common Stock | 25907 | $0.00 | 25,927.0000 | 0 | 9999.99% | 0.00% |
| Aug. 11, 2023 | Benitec Biopharma Inc. | $BNTC | Boston Megan | Executive Director | P | Common Warrants (right to buy) | 25907 | $0.00 | 25,907.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2023 | Benitec Biopharma Inc. | $BNTC | Boston Megan | Executive Director | A | Options (right to buy) | 153000 | $0.00 | 153,000.0000 | 0 | 9999.99% | 0.00% |